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Crystals of the complex between seryl-tRNA synthetase and tRNA7’ from Escherlchu colr have been obtained from ammonium sulphate solutions. 
The crystals are of the 1:2 enzyme:tRNA complex. belong to the space group C222,. have cell dimensions of u = 128.9 A, b = 164.9 A. c = 127.3 
A and diffract anisotropically from 3.5 to 4.5 A. An X-ray diffraction data set to 4 A has been collected. The combmatton of molecular replacement 
using the refined structure of the catalytic domain of the natrve enzyme, data from a heavy atom denvative and solvent flattening was used to 
produce a map at 4 A resolution. This shows that a tRNA molecule binds across the dimer, the anttcodon stem and loop do not contact the protein 
and the helical arm of the enzyme contacts the TYC loop and the long extra arm of the tRNA. 
Crystalhzation: Serine; Ammoacyl-tRNA synthetase; tRNA; X-ray structure 
1. INTRODUCTION 
A principal goal of structural molecular biology is the 
elucidation of the nature of the specific interactions be- 
tween biological macromolecules at the atomic level. 
The complexes formed by aminoacyl-tRNA synthetases 
and their cognate tRNAs are systems for both studying 
the interaction between RNA and protein and for un- 
derstanding important recognition steps in maintaining 
fidelity in protein biosynthesis. An obvious means to 
study these interactions is high resolution X-ray diffrac- 
tion analysis of suitable crystals. By this approach the 
interactions in the aminoacyl-tRNA synthetase:tRNA 
complexes for glutamine (from Escherichia coli) and 
aspartic acid (from yeast) have been described [1.2]. 
Recently the crystallization of similar complexes for the 
aspartic acid system from E. coli [3] and the serine sys- 
tem from Thermus thermophilus [4,5] have been re- 
ported. 
We have previously determined the structure of the 
E. coli seryl-tRNA synthetase to high resolution [6]. A 
remarkable feature of this structure is a 60 A helical 
arm-like domain that might be important for the recog- 
nition of E. coli serine isoacceptor tRNAs, which are 
characterised by the possession of long extra arms. In- 
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eluded in this group of tRNAs is the product of the selC 
gene, tRNA”“. which is responsible for the incorpora- 
tion of selenocysteine into proteins [7]. In the preceding 
report [8] we describe the cloning, overexpression and 
isolation of two tRNA”“‘s and here we describe our 
studies on the crystallization of E. coli seryl-tRNA syn- 
thetase:tRNA complexes. 
2. MATERIALS AND METHODS 
3.1. Seryl-rRNA synthetase 
Seryl-tRNA synthetase (SRSEC) was Isolated from an overex- 
pressing strain of E. ~011 as previously descrrbed [9]. 
2.2. tRNA,“’ 
Total tRNA (MRE 600) from Boehringer was dissolved in the 
smallest possible volume of buffer A (64.4 mM Trts, 50 mM HCl. 10 
mM MgCl,, I mM DTT, 0.1 mM PMSF. 1 mM NaN,. pH 7.6 at room 
temperature). This solutton was fractionated on a column of (2.5 x 90 
cm) of AcA 44 (IBF) equilibrated m the same buffer. The fractions 
contaming tRNA”’ as measured by a standard charging assay with 
[“‘Clserine [S], were pooled and precipitated with two volumes of 
ethanol, washed with 70% ethanol and dried; this treatment is mainly 
to remove pigment and any high or low molecular weight contam- 
ments of the tRNA fractron. Based on the acceptance activity for 
serme a sample of the tRNA was dissolved m a solution of SRSEC 
m buffer A containing 50 mM NaCl such that the molar ratio of 
enzyme to tRNA”” was about 21. This mixture was then fractionated 
by gel filtratron on AcA 44 eqmlibrated in buffer A. The first peak of 
the chromatogram contained the enzyme and complexed tRNA”‘. 
Fractions from this peak were pooled and applied to a small column 
of DEAE- Sepharose CL-6B (Pharmacta) equilibrated m buffer A. 
Thus column was washed with start buffer and developed with a hnear 
gradient of O&O.5 M NaCl in buffer A. Separate peaks of synthetase 
(peak 1) and tRNA (peak 2) were obtained. The pool of tRNA frac- 
ttons was then separated mto isoacceptors by hydrophobic interactton 
chromatography on phenyl-Superose (Phannacia) as described [S]. 
The tRNA of the major peak for serine acceptance was used in the 
crystalhzatton trrals and was asssumed to be tRNA,“‘. 
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2.3. tRNA,“’ 
This was isolated as described m the accompanymg report [S]. 
3 4. tRNA”’ _.
This tRNA was isolated from E co/i strain FM420 harbouring the 
plasmid pMNX1 as described [7] except that the first chromatographic 
separation was performed with BAPPS [lo] instead of BD-cellulose. 
Crystallization trials by the hanging drop/vapour diffusion proce- 
dure were performed on mixtures of seryl-tRNA synthetase with 
tRNA”’ isolated from commercial total tRNA presumed to be 
tRNA,“” [Ill, tRNA”‘. two fractions of tRNAF and the amber 
supressor tRNA described m the proceeding report [S]. The trials were 
carried out with ammomum sulphate, sodium citrate and polyethylene 
glycol solutions at various pH values between 5.8-8.0 with MES, Trls, 
Tris-maleate and imidazole buffers. 
DiffractIon data were collected on a laboratory rotating anode 
source with graphite monochromator and a FAST detector (CNRS. 
Grenoble) or double-focussing mirrors and Mar-Research Image- 
plate system (EMBL. Grenoble). Other data were collected on syn- 
chrotron beamhne W32 at LURE [12] usmg a Mar-Research Image- 
plate detector and a wavelength of 0.901 A. Raw data were processed 
either using MADNES and the Kabsch profile fittmg programmes 
PROCOR (FAST data) or the MOSFLM package for image-plate 
data [13] Subsequent data analysis was perfomed with the CCP4 
program package (Daresbury Laboratory, England) 
3. RESULTS 
3.1. Crystallization 
Crystals of the enzyme:tRNA complex were only ob- 
tained when the tRNA component was tRNA?‘“‘. These 
crystals generally appeared in about 6 days in drops 
containing 5 mg SRSEC/ml and 3.9 mg tRNA/ml (stoi- 
chiometric ratio protein:tRNA = 12.4). 10 mM MgCl?, 
1 mM DTT, 0.1 mM PMSF, 1 mM NaN3 in 50 mM 
MES-NaOH buffer pH 6.5 equilibrated against 45-50% 
saturated ammonium sulphate solution in the same 
buffer. Other trials using other buffering agents but at 
the same pH gave similar results. 
3.2. Crystallography 
The crystal symmetry and Bravais lattice of the crys- 
tals was determined to be C-centred orthorhombic by 
means of the MADNES auto-indexing routine of the 
FAST system and confirmed by subsequent data analy- 
sis. The cell dimensions are a = 128.9 A, b = 164.9 A, 
c = 127.3 A. The exact space-group is C222, (rather 
than C222) as determined during the molecular replace- 
ment procedure (see below). The crystals are rhombohe- 
dral prisms with the c-axis parallel to the long axis of 
the prism. They diffract anisotropically to about 3.54 
A in the directions a and c and only about 4.0-4.5 A in 
the b direction. A striking feature of the diffraction 
pattern is the extremely intense diffuse scattering. The 
implied disorder may be correlated to the relatively 
poor diffraction quality. 
A dataset has been collected to 4 A resolution using 
4 crystals on the wiggler beamline W32 at LURE with 
168 
a wavelength of 0.901 A, a crystal-image plate distance 
of 379 mm and a temperature of 2°C. From 24197 
measured reflections 9824 unique reflections were ob- 
tained (average redundancy of 2.5) with an Rmerge of 
8.8% (24.8% in the highest resolution bin) and com- 
pleteness of 83%. Since many of the most intense spots 
were absent from this data collection due to detector 
saturation, low resolution data was added from addi- 
tional measurements on a laboratory source. The final 
dataset contained 10,550 independent reflections (89% 
complete to 4 8, resolution). Data were also collected on 
the laboratory source with an image-plate detector on 
a methylmercury acetate derivative obtained by co-crys- 
tallization. Using two crystals 3328 independent reflec- 
tions were measured to 6 A resolution (Rmerge = 6%, 
92% complete). 
The refined 2.5 A structure of seryl-tRNA synthetase 
from E. co/i [6] was used as a search model for molecu- 
lar replacement. Since the helical arms of the molecule 
are known to have a variable orientation they were 
excluded from the model. However, a straightforward 
cross rotation function did not yield a significant solu- 
tion. Therefore a different stategy was employed. 
The unit cell volume suggest that the asymmetric unit 
of the crystal contains one synthetase monomer and one 
tRNA molecule (corresponding to a V,,, of 4.3 A”lDa). 
This implies that the molecular 2-fold axis is aligned 
with a crystallographic ‘-fold axis. The problem then 
reduces to a simple rotation search about the possible 
2-fold axes followed by a translation search along the 
axis. This procedure was performed with the pro- 
gramme BRUTE [14] for both possible space-groups. 
Only space-group C222, gave a significant solution 
(correlation of 0.50. for 5423 reflections betweeen 5 and 
15 A) which also gave a reasonable unit-cell packing. 
Program SIGMAA [15] was then used to calculate an 
electron density map from the model at 6 A resolution. 
This showed clear density for the helical arm of the 
synthetase (which had been ommitted from the search 
model), but in a significantly different orientation to 
that found in the native structure. In addition, extra 
density was also seen into which one tRNA,“” molecule 
(using a model built by E. Westhof) could be un- 
ambiguously placed. Upon re-adding the helical arm in 
the new orientation to the synthetase model, a rigid- 
body refinement using XPLOR [ 161 improved the corre- 
lation to 0.58 for the resolution range 5-15 A. 
The electron density map was improved by the fol- 
lowing procedure. Phases from the initial model for the 
protein were used to calculate a difference map with the 
data from the methyl-mercury acetate derivative. This 
clearly revealed two mercury sites which corresponded 
to the positions at Cys-338 (130) and Cys-374 (6.50) as 
previously found for the ethyl-mercury chloride deriva- 
tive of the native synthetase [6]. A anomalous difference 
map also showed the same sites. After phase refinement 
of the heavy-atom parameters. phases were calculated 
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using the mercury derivative isomorphous differences 
(mean figure of merit 0.40 for 2757 relections phased to 
6 8, resolution). These were combined (using SIGMAA) 
with model phases, calculated to 4 A resolution from the 
complete synthetase structure including the arm in its 
new orientation, giving a mean figure of merit of 0.49 
for 10,648 reflections to 4 A. From a new map at 4 A 
resolution an envelope was calculated using the auto- 
matic procedure of Leslie [17]. An envelope of the 
atomic model, including a complete synthetase mono- 
mer and the Westhof tRNA”” model placed in the den- 
sity, was also calculated. The union of the two envelopes 
(solvent content 57%, estimated solvent content in crys- 
tals 75%) was used in the solvent flattening procedure 
[ 181 and a final map calculated at 4 A resolution. After 
the first cycle of solvent flattening the mean figure of 
merit was 0.70 for 10,648 reflections to 4 A and con- 
verged to 0.89 after 8 cycles, although this value is 
clearly unrealistic. In the final map (see Fig. l), in which 
no tRNA model has been used to derive phase informa- 
tion (except very indirectly via the envelope procedure), 
the almost complete backbone trace of the tRNA is 
clearly visible (Fig. 1). However, the present resolution 
is not sufficiently good to build an accurate model. 
Nevertheless the considerable deviations in the 
tRNA,““’ structure from the initial tRNAzSe’ model ob- 
tained from E. Westhof (IBMC) are clearly visible. 
4. DISCUSSION 
The correctness of the structure determination is 
shown firstly by the location of the mercury sites at the 
same positions as found for the native synthetase and 
secondly by the clearly recognisable electron density for 
the tRNA molecule. At this stage, the following obser- 
vations can be made on the structure of the complex. 
(a) The asymmetric unit of the crystal contains one 
synthetase monomer and one tRNA molecule. The syn- 
thetase dimer carrying two tRNA molecules has exact 
2-fold symmetry. The tRNA binds across the dimer, i.e. 
the 3’ end, enters the active site of one subunit, whereas 
the bulk of the tRNA is on the other subunit. The 
direction of entry of the tRNA into the active site con- 
forms with that observed for the aspartyl-system, the 
other class 2 synthetase complex whose structure is 
known [2]. 
(b) The anticodon stem and loop are not in contact 
with the protein. This is consistent with several results 
showing that the anticodon is not important for synthe- 
tase recognition in the seryl-system [18]. Indeed in the 
crystals, two anticodon loops from two tRNA mole- 
cules related by a crystallographic 2-fold axis are in 
contact. A strong possibility (consistent with the low 
resolution electron density) is that the first two bases of 
the anticodon CGA form base-pairs with the self-com- 
Fig. 1. Stereo picture of the final 4 8, resolution electron density map contoured at 1.20 after phase combination and solvent flattemng as described 
in the text. The L-shaped tRNA”’ molecule is clearly visible as defined by the helical electron density of the backbone, with the acceptor stem entermg 
the enzyme active site at top left and the anticodon loop at the bottom. The helical arm of the synthetase is seen at the top right of the figure. A 
model of the tRNA molecule is supertmposed on the density. 
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plimentary bases of the second tRNA molecule. This 
hypothesis could explain the observation that the sup- 
pressor tRNA”’ which is identical to tRNAI’“’ except 
for having the anticodon CUA (in which the first two 
bases are not self-complimentary) has not been crystal- 
lized. 
(c) The helical arm of the synthetase is inserted be- 
tween, and makes contacts with, the TYC loop and the 
long variable arm of the tRNA. 
The model of the E. cofi seryl-tRNA synthetase- 
tRNA complex outlined above is very similar to that 
found independently from a study at 3.9 A resolution 
of crystals of the complex between seryl-tRNA synthe- 
tase and tRNA”” from Themus thernwphilus (Biou et 
al., manuscript in preparation; Yaremchuk et al. [5]). 
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